Oxo Chemie GmbH
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of WF 10 IV Solution in Patients With Advanced HIV Disease (NCT00002152) | Oxo Chemie GmbH | |
| A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection (NCT00002119) | Oxo Chemie GmbH |
Track Oxo Chemie GmbH automatically
Every clearance here is in the API, with alerts when new ones post.